InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-13.2%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Rodino-Klapac Louise, Directeur Scientifique. Officer active across 1 company, notably Sarepta Therapeutics, Inc.. Cumulatively, 24 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €267k. History available since 16 November 2021. The latest transaction was filed on 4 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Rodino-Klapac Louise
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
21,423 股@ US$22.22Common StockSEC:0001193125-26-385536:0
948 股@ US$17.030.5% 占其流量Common StockSEC:0001193125-26-106703:0
504 股@ US$16.950.3% 占其流量Common StockSEC:0001193125-26-102703:0
8,125 股Common StockSEC:0001193125-26-089425:0
4,582 股@ US$18.422.7% 占其流量Common StockSEC:0001193125-25-288556:0
93,875 股0Common StockSEC:0001193125-25-197425:0
5,500 股Common StockSEC:0000950170-25-037523:0
17,500 股Common StockSEC:0000950170-25-036694:0
1,704 股@ US$101.345.8% 占其流量Common StockSEC:0000950170-25-035002:0
715 股@ US$103.772.5% 占其流量Common StockSEC:0000950170-25-032759:0
4,558 股@ US$102.8915.7% 占其流量Common StockSEC:0000950170-24-129454:0
6,250 股Common StockSEC:0000950170-24-077521:0
512 股@ US$120.492.0% 占其流量Common StockSEC:0000950170-24-029532:0
1,728 股@ US$125.327.0% 占其流量Common StockSEC:0000950170-24-027496:0
778 股@ US$126.193.2% 占其流量Common StockSEC:0000950170-24-026607:0
4,508 股@ US$82.9812.1% 占其流量Common StockSEC:0001209191-23-056168:0
912 股@ US$153.194.7% 占其流量Common StockSEC:0001209191-23-018021:0
1,134 股@ US$157.215.9% 占其流量Common StockSEC:0001209191-23-017407:0
522 股@ US$147.572.6% 占其流量Common StockSEC:0001209191-23-016054:0
4,211 股@ US$108.5215.5% 占其流量Common StockSEC:0001209191-22-058284:0
1,216 股@ US$79.203.3% 占其流量Common StockSEC:0001209191-22-017343:0
572 股@ US$75.051.4% 占其流量Common StockSEC:0001209191-22-014409:0
3,780 股@ US$79.3310.0% 占其流量Common StockSEC:0001209191-21-066948:0
标准退出：2022年2月22日 (T+90)
40,000 股0Common StockSEC:0001209191-21-065314:0
24 条申报中的 24 条
About Rodino-Klapac Louise
Rodino-Klapac Louise is Directeur Scientifique and President, R&D and Tech Ops at Sarepta Therapeutics, Inc. She has 23 filings in total. Across the 23 sampled filings, buys total EUR 266669 and sells total EUR 0, with filings ranging from 2021-11-17 to 2026-03-13. The most common transaction nature is Tax withholding.
